Reportlinker finds all market research
reports published by official sources!
Company Report: Human Insulin in China and The United States for Year 2012
- This 3-page company report was published in July 2012.
Search ReportLinker
The Largest Collection of Market Research Reports
» 450,000 Company Profiles
» 40,000 Country Guides
From +200,000 authoritative sources
Drug And Medication Industry in China : Latest Downloads
The United Laboratories International Holdings Ltd. - Investment Analysis, December 2012
- Company report
- December 2012
- 4 pages
... And profit attributable to equity holders increased significantly overall business performance improved sales and r&d progress of human insulin products better than expected financial highlights ...
Company Report: Drug and Medication in China for Year 2012
- Company report
- December 2012
- 26 pages
- by Market Research Publisher
The United Laboratories International Holdings Ltd. - Company Report for Year 2012
- Company report
- August 2012
- 3 pages
... Products. As its new product had the same efficacy as that of imported ones and that the price was competitive, since the launch of recombinant human insulin in may 2011, the group has consistently ...
Merrill Lynch International - Company Report ...
12 months agoInvestor Presentation: Drug And Medication Fo ...
7 months agoBiocon Ltd. - Company Report For Year 2012
8 months agoCompany Report: Drug And Medication For Year ...
9 months agoCompany Report: Drug For Year 2013
2 months agoCompany Report: Anti-inflammatory For Year 20 ...
2 months agoCompany Report: Drug And Medication For Year ...
3 months agoMarket Figures
Drug And Medication Key Market Figures In China
3 months ago
More Reports:
Drug and Medication in Australia (22)
Company Reports
Country Reports
China
United States
Drug And Medication Industry in China : Latest Reports
BIOTON S.A. (Symbol:BIO) SWOT Analysis, Strategy, Revenues and Profits
- $ 250
- Company report
- November 2012
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
Peritoneal Tumor - Pipeline Review, H1 2013
- $ 2 000
- Company report
- March 2013
- by Global Markets Direct
Peritoneal Tumor - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Peritoneal Tumor - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report ...
World Therapy: Metastatic Melanoma - Pipeline Review, H1 2012
- $ 2 000
- Company report
- March 2013
- by Global Markets Direct
This report provides information on the therapeutic development for Metastatic Melanoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key ...
More Reports:
Drug and Medication in China (129)
Reportlinker.com © Copyright 2013. All rights reserved.
